Iridex announces second-generation MicroPulse P3 device

Iridex introduced the second generation of the MicroPulse P3 device to deliver greater stability, visualization, coupling and fit when treating patients with glaucoma, according to a press release.

The device features improvements such as a fiber tip with a fluid channel to enable consistent immersion during treatment to improve light coupling, concave scleral-matching footplate to improve stability, limbal-matching footplate curvature to identify orientation and placement, reduced footplate size and elongated stem to improve visualization of the treatment area.

“The launch of our revised MicroPulse P3 device represents an important step forward in simplifying our unique non-incisional glaucoma therapy,” David Bruce, CEO of Iridex, said in the release. “We are pleased with the initial physician users’ positive response to the product improvements. We anticipate these ease of use improvements will lead to greater physician confidence and adoption.”

Iridex introduced the second generation of the MicroPulse P3 device to deliver greater stability, visualization, coupling and fit when treating patients with glaucoma, according to a press release.

The device features improvements such as a fiber tip with a fluid channel to enable consistent immersion during treatment to improve light coupling, concave scleral-matching footplate to improve stability, limbal-matching footplate curvature to identify orientation and placement, reduced footplate size and elongated stem to improve visualization of the treatment area.

“The launch of our revised MicroPulse P3 device represents an important step forward in simplifying our unique non-incisional glaucoma therapy,” David Bruce, CEO of Iridex, said in the release. “We are pleased with the initial physician users’ positive response to the product improvements. We anticipate these ease of use improvements will lead to greater physician confidence and adoption.”